^ ei)wµtñ ao ¶Yí iuýZéuñgÊ -...
Transcript of ^ ei)wµtñ ao ¶Yí iuýZéuñgÊ -...
-
:
1) *
I.
II.
III.
IV.
.
.
I.
, .
1~100nm . ,
, . ,
, (10-9m) ,
. EU
(EC 1123/2009) ,
, , 1~100nm
.
OECD () , (Ag), (C),
(Fe), (TiO2), (AlO, Al2O3) (ZnO), (SiO2),
,
. ,
,
*
-
194 49(2010)
. ,
, .
, ,
.
.
.
( ) ,
.
, ,
,
(Khanna, 2008).
(colloid) ,
,
(Yamamoto, 2003).
(hydrosol) .
, (salt)
, NaBH4 .
,
(aggregation) .
, (capping material) (Olenin, 2008; Si, 2007).
(HCHO), (NaBH4), (citrate)
, (PA), (PVA),
(PVP) (PEG) .
(SDS) . /, Klebsiella pneumoniae
.
, ,
,
, ( , 2009).
. PVP
, ,
-
195
1234567891011121314
Silver nanoparticlesSingle-walled carbon nanotubes (SWCNTs)Multi-walled carbon nanotubes (MWCNTs)Fullerenes (C60)Iron nanoparticlesCarbon blackTitanium dioxideAluminum oxideCerium oxideZinc oxideSilicon dioxidePolystyreneDendrimersNanoclays
OECD
(a) PVP (b) PVP
: (2009).
(PVP) . , (DLS) ; , (TEM) .
Dp.57.1nm I
g
R
w
:--::;;-:-(---Q
z
g
Dp.5 om g
m
m
m
:--:iic--
(-a--
]
-z
-o. --
. 0
di:uutter (U l)
----.'
-
--.
"- ~
-~
I
-
196 49(2010)
( , 2009).
.
, OECD , ,
, , (Scientific Committee on Emerging and
Newly Identified Health Risks, 2006). ,
, .
, ,
(Yoon et al., 2004).
.
, ,
. 100
. ,
, . 2000
. 2000
. ,
. , , , ,
, .
. , ,
, , ,
.
. 100nm 1
, 100nm~1
30% (Hewett, 1995). , 100
.
,
(Yoon et al., 2004).
. 100nm~1
, 100nm 1
.
-
197
Fullerene , , , , IT
, ,
, , , , ,
, , , , ,
, , , , ,
, , MRI , , , ,
, , , ,
,
, , , , ,
, ,
, , ( ), ,
, ,
, (), , (),
, ,
, ,
, , , ,
, , , , ,
.
' 1
g
// '1
() ~
g I I
-
198 49(2010)
: Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), 2006.
.
,
. ,
.
. ,
. ,
. Ryman-Rasmussen (2006)
.
, , ,
. ,
.
.
1.000
0.800
I o6OO
gg 04OO
0.200
0.000 0.01 0.1 1.0 10.0
Pacle Diameter (microns)
-
199
.
, -
. , ,
, , . ,
OECD () .
, , , , , ,
.
1)
,
, . Kreyling (2002)
,
. , Elder (2006)
(olfactory bundle)
. ,
(Nurkiewicz et al., 2008). ,
, , , , ,
.
2)
Donaldson (2002)
. , ,
. , (broncho-alveolar fluid, BAL)
(Shvedova et al., 2007).
3)
DNA ,
(Li et al., 2007). ,
. In vitro ,
, - (Cunningham, 2007).
-
200 49(2010)
4)
(Takagi et al., 2008). ,
, (granuloma),1) (fibrosis) ,
. ,
(Muller et al., 2008).
5)
(Nurkiewicz et al., 2008).
(Radomski et al., 2005).
, ,
.
, ,
, . ,
, , ,
.
, , ,
, ,
,
. , ,
, ,
.
,
. (nominal
concentration) , ,
,
. ,
.
1) ) .
-
201
.
1)
,
. ,
. ,
. OECD (WPMN)
. OECD
.
, .
100nm .
.
. ,
. ,
,
.
2) ()
,
, .
,
. , (, )
. fullerene
,
, .
, , , .
,
.
,
-
202 49(2010)
(Physical-Chemical Properties and Material Characterization)
/(Agglomeration/aggregation) (Water solubility) (Crystalline phase)(Dustiness)(Crystallite size)TEM (Representative TEM picture(s)) (Particle size distribution)(Specific surface area) / (Zeta potentiall; surface charge) (Surface chemistry, where appropriate) (Photocatalytic activity) (Pour density)(Porosity)/ (Octanol-water partition coefficient, where relevant) (Redox potential) (Radical formation potential)
(Environmental Fate)
(Dispersion stability in water) (Biotic degradability)(Ready biodegradability) (Simulation testing on ultimate degradation in surface water)(Soil simulation testing) (Sediment simulation testing) (Sewage treatment simulation testing) (Identification of degradation product(s)) ( Further testing of degradation product(s) as required) (Abiotic degradability and fate) (Hydrolysis, for surface modified nanomaterials)-(Adsorption-desorption) (Adsorption to soil or sediment) (Bioaccumulation potential)
(Environmental Toxicology)
/ (Effects on pelagic species; short term/long term) / (Effects on sediment species; short term/long term)/ (Effects on soil species; short term/long term) (Effects on terrestrial species) (Effects on microorganisms)
(Mammalian Toxicology)
(Pharmacokinetics; ADME) (Acute toxicity)(Repeated dose toxicity)(Chronic toxicity)(Reproductive toxicity)(Developmental toxicity)(Genetic toxicity)
: OECD, GUIDANCE MANUAL FOR THE TESTING OF MANUFACTURED NANOMATERIALS: OECD SPONSORSHIP PROGRAMME; FIRST REVISION, ENV/JM/MONO(2009) 20/REV, 2010.
-
203
.
,
.
,
.
. ,
,
. ,
.
,
. , , ,
, , .
.
1)
.
.
, QA/QC .
2) .
, (, ,
, (, , ), ) .
3)
. ,
, . ,
.
4)
. .
, ,
.
5) - (quantitative
-
204 49(2010)
structure-toxicity relationship, QSTR) .
, . ,
. ,
, , ,
.
.
.
, QSTR
.
, . ,
"
, ,
.
,
. -
, , 1
.
,
.
, . ,
, , ,
- ,
. ,
,
.
, 2009, , , 12(3): 98-107.
, 2009,
, , 12(2): 59-73.
-
205
Cunningham, M.J., 2007, Genecellular interactions of nanomaterials: genotoxicity to genomics. In:
N.A. Monteiro-Riviere and C.L. Tran, Editors, Nanotoxicology Characterization, Dosing and
Health Effects, Informa healthcare, New York, USA.
Donaldson, K., D. Brown, A. Clouter, R. Duffin, W. MacNee, L. Renwick, V. Stone, 2002, The
pulmonary toxicology of ultrafine particles, J. Aerosol Med., 15: 213-220.
Elder, A., R. Gelein, V. Silva, T. Feikert, L. Opanashuk, J. Carter, R. Potter, A. Maynard, Y. Ito, J.
Finkelstein, G. Oberdrster, 2006, Translocation of inhaled ultrafine manganese oxide particles
to the central nervous system, Environ. Health Persp., 114: 1172-1178.
Hewett, P., 1995, The particle size distribution, density and specific surface are of welding fumes
from SMAW and GMAW mild and stainless steel consumables, American Industrial Hygiene
Association Journal, 56(2): 128-135.
Khanna, P., D. Kulkarni, R. Beri, 2008, Synthesis and characterization of myristic acid capped silver
nanoparticles, J. Nanoparticle Research, 10: 1059-1062.
Kreyling, W.G., M. Semmler, F. Erbe, P. Mayer, S. Takenaka, H. Schulz, G. Oberdrster, A.
Ziesenis, 2002, Translocation of ultrafine insoluble iridium particles from lung epithelium to
extrapulmonary organs is size dependent but very low, J. Toxicol. Environ. Health, Part A. 65:
1513-1530.
Li, W.X., J.Y. Xu, X.Q. Cai, R.L. Liu, Y.J. Li, Q.F. Zhao, Q.N. Li, 2007, Comparative study of
pathological lesions induced by multiwalled carbon nanotubes in lungs of mice by intratracheal
instillation and inhalation, Environ. Toxicol., 22(4): 415-421.
Muller, J., I. Decordier, P.H. Hoet, N. Lombaert, L. Thomassen, F. Huaux, D. Lison, M.
Kirsch-Volders, 2008, Clastogenic and aneugenic effects of multi-wall carbon nanotubes in
epithelial cells, Carcinogenesis, 29: 427-433.
Nurkiewicz, T.R., D.W. Porter, A.F. Hubbs, J.L. Cumpston, B.T. Chen, D.G. Frazer, V. Castranova,
2008, Nanoparticle inhalation augments particle-dependent systemic microvascular dysfunction,
Particle and Fibre Toxicology, 5: 1-12.
Olenin A.Y., Y.A. Krutyakov, A.A. Kudrinskii, G.V. Lisichkin, 2008, Formation of surface layers on
silver nanoparticles in aqueous and water-organic media, Colloid J, 70: 71-6.
Radomski, A., P. Jurasz, D. Alonso-Escolano, M. Drews, M. Morandi, T. Malinski, M.W. Radomski,
2005, Nanoparticle-induced platelet aggregation and vascular thrombosis, Brit. J. Pharmacol.,
146(6): 882-893.
Ryman-Rasmussen, J.P., J.E. Riviere, N.A. Monteiro-Riviere, 2006, Penetration of intact skin by
quantum dots with diverse physicochemical properties, Toxicol. Sci., 91(1): 159-165.
-
206 49(2010)
Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), The
appropriateness of existing methodologies to assess the potential risks associated with engineered
and adventitious products of nanotechnologies (2006).
Shvedova, A.A., T. Sager, A.R. Murray, E. Kisin, D.W. Porter, S.S. Leonard et al., 2007, Critical
issues in the evaluation of possible adverse pulmonary effects resulting from airborne
nanoparticles. In: N.A. Monteiro-Riviere and C.L. Tran, Editors, Nanotoxicology
Characterization, Dosing and Health Effects, Informa Healthcare, New York, USA.
Si S, T.K. Mandal, 2007, Tryptophan-based peptides to synthesize gold and silver nanoparticles: a
mechanistic and kinetic study, Chem Eur J, 13: 3160-8.
Takagi, A., A. Hirose, T. Nishimura, N. Fukumori, A. Ogata, N. Ohashi, S. Kitajima, J. Kanno, 2008,
Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon
nanotube, J. Toxicol. Sci., 33(1): 105-116.
Yamamoto, M., M. Nakamoto, 2003, Novel Preparation of Monodispersed Silver Nanoparticles Via
Amine Adducts Derived from Insoluble Silver Myristate in Tertiary Alkylamine, J. Mat. Chem.,
13: 2064-65.
Yoon, C.S., 2004, Welding fume and others from welding processes, Korean Journal of
Environmental Health, 30(4): 320-328.
: . . . . . .